Choline analogues in malaria chemotherapy (Q26851323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2 references

2 October 2023

14 January 2024

Choline analogues in malaria chemotherapy (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

12 November 2019

1 reference

22 October 2019

1 reference

12 November 2019

1 reference

18 July 2021

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1

Suzanne Peyrottes

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

6

Henri Vial

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2

Sergio Caldarelli

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

5

Alain Pellet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

4

Christian Périgaud

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

1 reference

1 January 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

Current Pharmaceutical Design

1 February 2020

published in

11 references

23 March 2019

22 June 2019

30 June 2019

22 October 2019

7 November 2019

12 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

18 July 2021

2 October 2023

14 January 2024

18

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

24

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

3454-3466

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 2.5 Generic

1 February 2020

copyright license

9 references

23 March 2019

22 June 2019

30 June 2019

22 October 2019

7 November 2019

12 November 2019

18 July 2021

2 October 2023

on focus list of Wikimedia project

14 January 2024

ScienceSource

0 references

cites work

Artemisinin resistance: current status and scenarios for containment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

The Kennedy phospholipid biosynthesis pathways are refractory to genetic disruption in Plasmodium berghei and therefore appear essential in blood stages

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

The antimalarial ferroquine: from bench to clinic

25 May 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

The state of the art in anti-malarial drug discovery and development

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Glycerophospholipid acquisition in Plasmodium - a puzzling assembly of biosynthetic pathways

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Quinolines and structurally related heterocycles as antimalarials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

The global portfolio of new antimalarial medicines under development.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Potent antihematozoan activity of novel bisthiazolium drug T16: evidence for inhibition of phosphatidylcholine metabolism in erythrocytes infected with Babesia and Plasmodium spp.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Dual molecules as new antimalarials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Prodrugs of bisthiazolium salts are orally potent antimalarials

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

MODIFIED THIAMINE COMPOUNDS

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

In vivo antimalarial activities of mono- and bis quaternary ammonium salts interfering with Plasmodium phospholipid metabolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Potent inhibitors of Plasmodium phospholipid metabolism with a broad spectrum of in vitro antimalarial activities

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Heme binding contributes to antimalarial activity of bis-quaternary ammoniums

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

A class of potent antimalarials and their specific accumulation in infected erythrocytes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

The chemosensitivity of the rodent malarias--relationships with the biology of merozoites

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Thiamine Propyl Disulfide: Absorption and Utilization

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Quaternary ammonium compounds efficiently inhibit Plasmodium falciparum growth in vitro by impairment of choline transport

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Malarial lipids. An overview

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Unraveling the mode of action of the antimalarial choline analog G25 in Plasmodium falciparum and Saccharomyces cerevisiae

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Antimalarial activity of 77 phospholipid polar head analogs: close correlation between inhibition of phospholipid metabolism and in vitro Plasmodium falciparum growth

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Antimalarial activity of molecules interfering with Plasmodium falciparum phospholipid metabolism. Structure-activity relationship analysis

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Phospholipid metabolism as a new target for malaria chemotherapy. Mechanism of action of D-2-amino-1-butanol

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Regulation of phosphatidylcholine biosynthesis in Plasmodium-infected erythrocytes

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Exploration of potential prodrug approach of the bis-thiazolium salts T3 and T4 for orally delivered antimalarials.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Synthesis and evaluation of bis-thiazolium salts as potential antimalarial drugs

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

When is enough enough? The need for a robust pipeline of high-quality antimalarials.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Mono- and bis-thiazolium salts have potent antimalarial activity

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3480700

Comparative bioavailability of various thiamine derivatives after oral administration

28 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/22607139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Antimalarial activity of compounds interfering with Plasmodium falciparum phospholipid metabolism: comparison between mono- and bisquaternary ammonium salts

1 reference

https://pubmed.ncbi.nlm.nih.gov/22607139

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.2174/138161212801327338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22607139%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

2 references